Sean McCutcheon
Stock Analyst at Raymond James
(n/a)
# 4,471
Out of 4,827 analysts
5
Total ratings
n/a
Success rate
-42.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ENGN enGene Holdings | Initiates: Outperform | $23 | $3.63 | +533.61% | 1 | Nov 27, 2024 | |
| XNCR Xencor | Maintains: Strong Buy | $58 → $40 | $8.51 | +370.31% | 1 | Jun 14, 2024 | |
| CYTK Cytokinetics | Maintains: Outperform | $92 → $70 | $33.97 | +106.06% | 2 | May 23, 2024 | |
| LEGN Legend Biotech | Initiates: Outperform | $86 | $31.43 | +173.67% | 1 | Mar 13, 2024 |
enGene Holdings
Nov 27, 2024
Initiates: Outperform
Price Target: $23
Current: $3.63
Upside: +533.61%
Xencor
Jun 14, 2024
Maintains: Strong Buy
Price Target: $58 → $40
Current: $8.51
Upside: +370.31%
Cytokinetics
May 23, 2024
Maintains: Outperform
Price Target: $92 → $70
Current: $33.97
Upside: +106.06%
Legend Biotech
Mar 13, 2024
Initiates: Outperform
Price Target: $86
Current: $31.43
Upside: +173.67%